1.
Pharmdca
@Pharmdca
CrowdStrike placed furthest right in the Completeness of Vision axis in 2022 Gartner Magic Quadrant for Endpoint… twitter.com/i/web/status/1…
Retweet of status by @CrowdStrike
2.
Pharmdca
@Pharmdca
BOOM
And here comes the 1st Biotech Buyout of 2023
$PRVB acquired by $SNF for $25 per share.
270% premium from… twitter.com/i/web/status/1…
And here comes the 1st Biotech Buyout of 2023
$PRVB acquired by $SNF for $25 per share.
270% premium from… twitter.com/i/web/status/1…
3.
4.
5.
6.
7.
Pharmdca
@Pharmdca
$TSLA shorts were talking about P/E close to $100s last month
Retweet of status by @BigBullCap
Pharmdca
@Pharmdca
Boom Another portfolio winner $HZNP
$HZNP Amgen to acquire Horizon Therapeutics for $116.5/shr in ~$20B deal
$XBI
$HZNP Amgen to acquire Horizon Therapeutics for $116.5/shr in ~$20B deal
$XBI
PharmD
@Pharmdca
Very Late press release $BLUE
bluebird bio Receives FDA Accelerated Approval for SKYSONA Gene Therapy for Early,… twitter.com/i/web/status/1…
bluebird bio Receives FDA Accelerated Approval for SKYSONA Gene Therapy for Early,… twitter.com/i/web/status/1…
PharmD
@Pharmdca
$SPY puts
PharmD
@Pharmdca
$NBEV filed for bankruptcy maybe next one to hit 1 @Kevin_W81
8.
9.
10.
11.
PharmD
@Pharmdca
will talk about these new @SoFi ETF later today on @CNBC twitter.com/sofi/status/15…
Retweet of status by @anthonynoto
PharmD
@Pharmdca
$ABEO $3.9's
Around $60M cash, funded into 2024,$24M market cap. Top-line data Q3 2022. Low float 5.8M shares.… twitter.com/i/web/status/1…
Around $60M cash, funded into 2024,$24M market cap. Top-line data Q3 2022. Low float 5.8M shares.… twitter.com/i/web/status/1…
Retweet of status by @Kevin_W81
PharmD
@Pharmdca
We survived first half of 2022
PharmD
@Pharmdca
Most of us chase inflated prices but not willing to add during deflation when market offering huge discounts in good companies
...but wait! There's more!
1.
fakhright
@fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
